ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
0.00%
US Tech 100
19,205.60
1.03%
Dow Jones
40,287.53
0.00%
Brent Oil
81.305
-1.18%
Bitcoin
67,804.97
-0.52%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Voyager Therapeutics Inc (VYGR)

  7. Voyager Therapeutics Inc (VYGR) News

VYGR

Voyager Therapeutics (VYGR)

Voyager Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VYGR
DateTimeSourceHeadlineSymbolCompany
07/09/20244:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
07/09/20244:10PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
07/09/20244:01PMGlobeNewswire Inc.Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VYGRVoyager Therapeutics Inc
06/13/20244:01PMGlobeNewswire Inc.Voyager Therapeutics to Present at Multiple Virtual Investor ConferencesNASDAQ:VYGRVoyager Therapeutics Inc
06/13/20247:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
06/13/20247:00AMGlobeNewswire Inc.Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial OfficerNASDAQ:VYGRVoyager Therapeutics Inc
06/07/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
06/07/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
06/07/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
06/07/20244:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
06/07/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
06/06/20244:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
05/16/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
05/16/20247:00AMGlobeNewswire Inc.Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s DiseaseNASDAQ:VYGRVoyager Therapeutics Inc
05/13/20244:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VYGRVoyager Therapeutics Inc
05/13/20244:01PMGlobeNewswire Inc.Voyager Therapeutics Reports First Quarter 2024 Financial and Operating ResultsNASDAQ:VYGRVoyager Therapeutics Inc
05/13/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
05/08/20246:00AMGlobeNewswire Inc.Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual MeetingNASDAQ:VYGRVoyager Therapeutics Inc
05/06/20247:00AMGlobeNewswire Inc.Voyager Therapeutics Announces First Quarter 2024 Conference Call and WebcastNASDAQ:VYGRVoyager Therapeutics Inc
04/22/20244:30PMGlobeNewswire Inc.Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual MeetingNASDAQ:VYGRVoyager Therapeutics Inc
04/16/20247:00AMGlobeNewswire Inc.Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone PaymentNASDAQ:VYGRVoyager Therapeutics Inc
03/26/20244:01PMGlobeNewswire Inc.Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VYGRVoyager Therapeutics Inc
03/13/20247:00AMGlobeNewswire Inc.Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical OfficerNASDAQ:VYGRVoyager Therapeutics Inc
02/28/20244:01PMGlobeNewswire Inc.Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating ResultsNASDAQ:VYGRVoyager Therapeutics Inc
02/28/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
02/26/20247:00AMGlobeNewswire Inc.Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone PaymentNASDAQ:VYGRVoyager Therapeutics Inc
02/22/20244:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/22/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/21/20243:16PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/21/20243:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VYGR

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
SPZI
Spooz (PK)
USOTC
HIRU
Hiru (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
VPLM
Voip Pal Com (QB)
COIN
BTCUSD
Bitcoin
USOTC
AABB
Asia Broadband (PK)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
COOP
Mr Cooper
USOTC
BLEG
Branded Legacy (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
AMRN
Amarin
NASDAQ
MAXN
Maxeon Solar Technologies
USOTC
DBMM
Digital Brand Media and ... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved